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Molecular chaperones are pivotal in folding and degradation of the cellular proteome but their
impact on the conformational dynamics of near-native membrane proteins with disease
relevance remains unknown. Here we report the effect of chaperone activity on the functional
conformation of the temperature-sensitive mutant cystic ﬁbrosis channel (ΔF508-CFTR) at
the plasma membrane and after reconstitution into phospholipid bilayer. Thermally induced
unfolding at 37 °C and concomitant functional inactivation of ΔF508-CFTR are partially
suppressed by constitutive activity of Hsc70 and Hsp90 chaperone/co-chaperone at the
plasma membrane and post-endoplasmic reticulum compartments in vivo, and at single-
molecule level in vitro, indicated by kinetic and thermodynamic remodeling of the mutant
gating energetics toward its wild-type counterpart. Thus, molecular chaperones can con-
tribute to functional maintenance of ΔF508-CFTR by reshaping the conformational ener-
getics of its ﬁnal fold, a mechanism with implication in the regulation of metastable ABC
transporters and other plasma membrane proteins activity in health and diseases.
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Cellular protein homeostasis (proteostasis) networks,including molecular chaperones, have evolved to maintainthe functional proteome1, 2. Heat shock protein 90
(Hsp90) and 70 (Hsp70/HSPA1A and Hsc70/HSPA8) in concert
with co-chaperones facilitate the folding of nascent chains and the
refolding of stress-denatured and aggregation prone polypeptides
by shielding exposed hydrophobic surfaces, as well as triaging
terminally unfolded polypeptides1. The Hsp70 family members
preferentially recognize unfolded proteins, whereas Hsp90 cha-
perones bind to partially folded intermediates and account for
maintaining the active conformation of their clients2, 3. It was
proposed that the buffering capacity of chaperones could enhance
genetic diversity4. In response to proteotoxic stresses, chaperones
may mask deleterious changes in the folding energy landscape1, 5,
which can be beneﬁcial in a changing environment.
While it is widely accepted that molecular chaperones assist the
folding of soluble proteins by suppressing misfolding and
aggregation, evidence that chaperones affect the conformational
search by altering the folding landscape energetics is still limited
and debated6. Although favorable kinetic modulation of the
folding pathway by chaperones was recently demonstrated7, 8, we
have no evidence regarding energetic stabilization of the ﬁnal fold
(s) of polypeptides, a central assumption to explain the pheno-
typic buffering capacity of chaperone networks of marginally
stable client proteins1, 5.
Whereas alterations of secondary structural elements9 and the
folding energy landscape of soluble polypeptides by the cytoplasm
have been reported10, the contribution of molecular chaperones
to these processes are not known. The ﬁrst direct evidence for a
favorable impact on the energetic landscape of the denatured
FhuA beta-barrel outer membrane protein by the Escherichia coli
holdase chaperones SurA and Skp was recently reported11.
Chaperone activity of the Hsp70 homolog, DnaK12, and the
Trigger Factor8 could also improve the refolding kinetics of
soluble model proteins12, and by analogy, may have a similar
effect on the cytosolic regions of multidomain membrane pro-
teins as well.
Preserving plasma membrane (PM) proteostasis is particularly
critical for ﬁne-tuning the activity of protein networks responsible
for signal transduction, cell–cell communication, ion home-
ostasis, cell migration, and nutrient uptake. Chaperones have
been implicated in the recognition, ubiquitination, internaliza-
tion, and lysosomal degradation of several conformationally
impaired PM proteins that are destabilized by missense muta-
tions, but can partially escape the endoplasmic reticulum (ER)
quality control (QC)13. It is plausible that molecular chaperones
not only contribute to the degradation13, but also to the con-
formational maintenance of multidomain membrane proteins in
post-ER compartments, representing ∼30% of the eukaryotic
proteome, considering their complex domain architecture and the
intrinsic thermodynamic instability2, 14.
Cystic ﬁbrosis transmembrane conductance regulator (CFTR)
protein is a member of the ATP-binding cassette (ABC) trans-
porter superfamily and comprises two membrane-spanning
domains (MSD1 and MSD2) and three cytosolic domains, two
nucleotide-binding domains (NBD1 and NBD2) and the
unstructured regulatory domain (RD)15. We selected the most
common cystic ﬁbrosis (CF)-causing mutant, the deletion of the
F508 residue (ΔF508) in CFTR, to assess the consequence of
molecular chaperon activity on the conformational energetics and
function of marginally stable PM proteins that can escape the ER
quality control15.
The cAMP-dependent protein kinase (PKA) stimulated
chloride transport activity and density of CFTR variants was
monitored as the read-out for the channel functional conforma-
tion both at the ensemble level at the PM of airway epithelia and
HeLa cells, as well as at the single-molecule level after the channel
reconstitution into black lipid membrane (BLM)16. Here, we
provide evidence that the cytosolic Hsc70/Hsp90 chaperone
systems contribute to the conformational and functional main-
tenance of the PM resident ΔF508-CFTR at 37 °C. In support,
molecular chaperone systems can partially rescue the thermal
unfolding-induced functional inactivation of reconstituted
ΔF508-CFTR in BLM, reﬂected by the remodeling of the channel
gating energetics towards that of the wild type (WT). These
ﬁndings demonstrate a mechanistic aspect of the profolding
activity of chaperones on a mutant PM protein, with implications
in phenotypic modulation of genetic and acquired conforma-
tional diseases.
Results
The ΔF508 mutation, located in the NBD1, disrupts the CFTR
domain folding and cooperative domain assembly by destabiliz-
ing the NBD1 and the NBD1and MSD1–2 interfaces17–20.
The temperature-sensitive folding and stability defect of the
ΔF508-CFTR permits its conditional rescue from ER associate
degradation at 26 °C and accumulation at the PM21. Pharmaco-
logical chaperones22 and proteostasis modulators23 can also
attenuate ΔF508-CFTR misprocessing and misfolding. Regardless
of the rescue method, the mature ΔF508-CFTR tends to unfold at
post-Golgi compartments at 37 °C, as indicated by its increased
protease susceptibility, aggregation propensity, and reduced
functional and biochemical half-lives (t1/2∼1–3 h) as compared to
WT (t1/2∼10–12 h)16, 24–26. Intriguingly, both the ΔF508-CFTR
folding efﬁciency at the ER, as well as its stability in post-Golgi
compartments and in BLM are increased by the pharmacological
chaperone, VX-80922, 27. Since the residual chloride secretion via
the ΔF508-CFTR that escapes the ER retention correlates with CF
disease severity in primary epithelia28, it is tempting to speculate
that this near-native channel population is not only subjected to
chaperone-dependent degradation24, but, perhaps, to refolding
as well.
Chaperones recognize ΔF508-CFTR in post-Golgi compartments.
To exert profolding activity, molecular chaperones should
recognize the partially unfolded ΔF508-CFTR in post-Golgi
compartments. To test this prediction, complex-glycosylated
ΔF508-CFTR (or band C, Fig. 1a) was accumulated at 26 °C for
2 days in stably transfected Baby Hamster Kidney (BHK) cells.
Then, to preserve the near-native conformation or unfold the
rescued ΔF508-CFTR, cycloheximide (CHX) chase was per-
formed at 26 °C for 10 h or at 37 °C for 2 h, respectively.
The CHX-chase ensured the elimination of partially folded core-
glycosylated ΔF508- and WT-CFTR from the ER (band B,
Fig. 1a), representing folding intermediates prone to chaperone
association19. Quantitative co-immunopreciptation (Co-IP)
showed that unfolding at 37 °C increased the association
of complex-glycosylated ΔF508-CFTR with Hsc70, Hsp90
(Fig. 1a, b) and some of their respective co-chaperones, Hdj1 and
Aha1 (Fig. 1c)29, 30, as compared to near-native ΔF508 (26 °C)
or WT (37 °C) (Fig. 1b, c). Consistent with ATP-dependent
substrate release from Hsc70, ATP depletion of the cell
lysate by apyrase augmented the Co-IP of Hsc70 with the
complex-glycosylated ΔF508-CFTR (Fig. 1b). These results
demonstrate that unfolded ΔF508-CFTR is recognized by the
Hsc70/Hsp90 systems in post-Golgi compartments.
Chaperones increase ΔF508-CFTR biochemical stability.
If Hsc70/Hsp90 activity favorably inﬂuences the ΔF508-CFTR
conformational stability and function at the PM, chaperone
inhibition should promote ΔF508-CFTR unfolding and
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degradation by the peripheral QC in post-Golgi compartments.
This was indeed the case. At 37 °C the complex-glycosylated
ΔF508-CFTR disappearance was augmented upon inhibition of
Hsp90 by geldanamycin (GA) or Hsp70/Hsc70 by apoptozole
(Apo, inhibits ATPase turnover) and Piﬁthrin-μ (Pif, inhibits
substrate binding)31 during a 1.5 h CHX chase, monitored by
immunoblotting in BHK-21 cells (Fig. 1d). GA and Pif or Apo
additively stimulated the mutant disappearance (Fig. 1d),
suggesting that both chaperone systems contribute to the con-
formational stabilization of the ΔF508-CFTR in post-Golgi
compartments.
Conformational stabilization of the mature ΔF508-CFTR by
Hsc70/Hsp90 was assessed by limited trypsinolysis of micro-
somes, isolated from BHK-21 cells20. The protease susceptibility
of the complex-glycosylated ΔF508-CFTR was increased by
~twofold after GA + Pif treatment of BHK-21 cells at 37 °C for
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Fig. 1Molecular chaperone activity maintains the limited transport competence of ΔF508- and P67L-CFTR. a Hsc70 and Hsp90 association with WT- and
ΔF508-CFTR containing a C-terminal HA-tag in BHK-21 cells by co-immunoprecipitation (Co-IP) and immunoblotting. Low-temperature rescued ΔF508-
CFTR (rΔF508-CFTR, 24 h, 26 °C, lanes 3–6), the channel was either unfolded for 2.5 h at 37 °C in the presence of 150 μg ml−1 cycloheximide (CHX) (lanes
4–6) or exposed to 37 °C for 20min and then cultured at 26 °C for 12 h with CHX. The latter protocol preserved the near-native conformation of the
complex-glycosylated form (band C, ﬁlled arrowhead), while ensured degradation of the core-glycosylated form (band B, empty arrowhead, lane 3). WT-
CFTR cells were exposed to CHX (2.5 h, 37 °C, lane 1). CFTR was IP with anti-HA antibody in the absence or presence of 2 mM ATP plus 1 mM MgCl2 ( +
ATP) or with 150 Uml−1 Apyrase ( + Apy) and the IP was probed for Hsc70/Hsp90. Parental (lane 7) and non-rescued ΔF508-CFTR (lane 2) BHK-21 cells
served as controls. b Hsc70 or Hsp90 fold-association with the complex-glycosylated rΔF508-CFTR was expressed relative to that observed after
unfolding 37 °C for 2.5 h. Data are means± standard error of the mean (SEM), n= 3–4. c Co-IP of co-chaperones with CFTR after crosslinking with 0.1 mM
dithiobis[succinimidyl propionate] (DSP) was performed after exposing the cells to CHX chase (2.5 h, at 26 or 37 °C) as described for a. d The effect of
Hsp70/Hsp90 inhibitors on the rΔF508-CFTR turnover, measured by quantitative immunoblotting. Rescued ΔF508-CFTR (26 °C, 48 h) was unfolded for
1.5 h at 37 °C in the absence or presence of Hsc70 (1 μM pifthrin μ [Pif] or 1 μM apoptozole [Apo]) or Hsp90 (10 μg ml−1 GA) inhibitor plus 150 μg ml−1
CHX. Na+/K+-ATPase served as loading control. Densitometric analysis of rΔF508-CFTR band C remaining after 1.5 h CHX chase. Data are means± SEM,
n= 3–4. e Limited trypsinolysis of ΔF508-CFTR in microsomes. Microsomes were isolated from BHK-21 cells that were exposed to DMSO or 5 μM Pif and
5 μg mlα GA (2 h, 37 °C) as described in Methods. Remaining complex-glycosylated rΔF508-CFTR was expressed as the percentage of the initial amount
(bottom panel). Means± SEM, n= 3–4
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2 h, measured by the trypsin concentration required for the 50%
degradation of the channel, and probed by immunoblotting
(Fig. 1e). This result indicates that Hsc70/Hsp90 activity
suppresses the unfolding propensity of the complex-glycosylated
ΔF508-CFTR in post-Golgi compartments. Notable, chaperones
only partially counteract the mutant unfolding propensity, as the
complex-glycosylated ΔF508-CFTR had ~10-fold increased
proteases susceptibility at 37 °C as compared to that at 26 °C24.
Estimating single CFTR activity by ensemble measurements.
Unfolding of near-native ΔF508-CFTR at the PM is conceivably
associated with its functional defect at 37 °C, followed by
its ubiquitin-dependent internalization and degradation24. The
kinetic coupling of these processes is not known. Since the
macroscopic transport function of PM CFTR, determined by
the channel number, conductance, and open probability, could be
targeted by chaperone regulation, both the transport activity and
PM density of the mutant were monitored upon modulation of
chaperone activity. PKA-stimulated CFTR chloride transport was
determined by short circuit current (Isc) or halide-sensitive YFP
quenching in the human CF bronchial epithelial cell line
(CFBE14o- depicted as CFBE) or HeLa cells. The PM density of
CFTR was monitored by cell-surface ELISA24.
We estimated CFTR activation at the single channel level by
normalizing the maximal PKA-activated CFTR anion transport
with the channel density, a readout designated as Fractional PM
Activity (FPMA). The FPMA was validated by demonstrating its
increase from ~0.2 to ~0.8–1 upon correction of the ΔF508-
CFTR gating defects in the presence of genistein to FPMA similar
to that of WT activation in CFBE cells regardless of VX-809
mediated folding correction (Fig. 2a).
Chaperones delay thermal inactivation of ΔF508-CFTR at PM.
To assess the role of major chaperone systems in the maintenance
of CFTR conformation, ﬁrst they were inhibited by validated
siRNA. Hsc70 ablation increased the ΔF508-CFTR PM density
by ∼threefold in CFBE relative to that in non-targeted (NT)
siRNA treated cells (Supplementary Fig. 1a, Fig. 2b). Since
ΔF508-CFTR activity remained unaltered, measured with YFP
assay (Supplementary Fig. 1b), the relative FPMA was reduced by
>60% as compared to NT siRNA exposed cells (Fig. 2b). Similar,
but less pronounced changes in the FPMA were observed upon
downregulation of Hsp70, Hsp90α, Hsp90β, and some of the
co-chaperones tested (Aha1, DNAJA1, and DNAJA2) (Fig. 2b,
Supplementary Fig. 1b, c).
Given the inﬂuence of major chaperone systems in the channel
conformational maturation and ER degradation32, as well as the
profound upregulation of Hsp70, Hsp90α, and Bip after siHsc70
transfection (Supplementary Fig. 1a, d)24, we switched to short-
term (2 h) pharmacological inhibition of chaperones to reduce the
indirect effects of siRNA treatments on ΔF508-CFTR folding/
stability. Inhibition of Hsc70/Hsp70 or Hsp90 with Pif or GA,
respectively, reduced the mutant FPMA in CFBE after 2 h
incubation, while had marginal effect on the cellular stress
response (Fig. 2c, d). Inhibition of both Hsc70 and Hsp90 acted
additively and led to 54± 6% decrease of the mutant FMPA as
compared to WT-CFTR (20± 4%, p< 0.01) (Fig. 2c, d).
Similar results were obtained by using the structurally distinct
Hsc70/Hsp70 (Apo and MKT-077 [MKT], an allosteric inhibitor
of ATP turnover or Hsp90 (Genitispib [Gpib]) alone or
in combination (Supplementary Fig. 1e, f), supporting the
contribution of both Hsp90 and Hsp70/Hsc70 systems to the
conformational maintenance of ΔF508-CFTR at the PM and in
post-ER compartments in CFBE. Similar changes were observed
in HeLa cells (Supplementary Fig. 1g).
The engagement of molecular chaperones in the conforma-
tional rescue of P67L-CFTR, another CF-causing processing
mutant, was also evaluated. Pharmacological inhibition of Hsp90
+ Hsc70 (37 °C, 2 h) reduced the FPMA of P67L signiﬁcantly
more than the WT (35.7± 5 vs. 20± 4%, p< 0.05) (Fig. 2d, e).
This result indicates that the conformational maintenance activity
of chaperones is not restricted to ΔF508-CFTR.
Modulation of ΔF508-CFTR chaperone-sensitivity at PM.
If the Hsc70/Hsp90 activity partially suppresses the intrinsic
instability of the PM ΔF508-CFTR, genetic or pharmacological
conformational stabilization should render the mutant resistant
to chaperone inhibition and vice versa. Indeed, suppressor
mutations (3S and/or R1070W, deﬁned in Supplementary
Table 1) largely preserved the FPMA of ΔF508-CFTR at the
WT level upon chaperone inhibition (Fig. 2f), consistent with
the increased protease resistance of ΔF508-CFTR-3S-R1070W
relative to ΔF50820. Remarkable, comparable chaperone-
resistance was documented after VX-809 treatment, an FDA
approved pharmacological chaperone that binds to and stabilizes
the ΔF508-CFTR22, 27, 33 (Fig. 2g). VX-809 also delayed the
mutant channel accelerated lysosomal delivery in the presence of
GA + Pif (Supplementary Fig. 2a, b). Conversely, destabilizing
ΔF508-CFTR at the ER and PM by exposing the CFBE
to the potentiator drug, ivacaftor (VX-770)34, enhanced the
contribution of chaperones to the conformational maintenance,
as revealed by the augmented downregulation of ΔF508-CFTR-3S
upon chaperone inhibition (Supplementary Fig. 2c, d). These
results, collectively, suggest that the Hsc70/Hsp90 chaperone
network partially counteracts the conformational and biochem-
ical destabilization of ΔF508-CFTR in post-Golgi compartments,
including the PM and endosomes.
Thermal inactivation of ΔF508-CFTR in black lipid membrane.
To conclusively demonstrate the impact of recombinant chaper-
one activity on the near-native ΔF508-CFTR unfolding, ﬁrst we
reconstituted the mutant into black lipid membrane (BLM) to
observe its inactivation process. Following in vitro phosphoryla-
tion, CFTR containing microsomes20 were fused to the BLM in a
thermostated chamber16 at ~24 °C. This technique ensured
sustained phosphorylation of CFTR after addition of the PKA
catalytic subunit and in the absence of endogenous phosphatases
(Supplementary Fig. 3a)35. Furthermore, microsome reconstitu-
tion rendered the BLM virtually free of cytosolic chaperones and
permitted monitoring the mutant activity without proteolytic
degradation (Supplementary Fig. 3b).
CFTR gating was routinely monitored upon increasing the
temperature from 23 to 36 °C at ∼1.4 °Cmin−1 rate at −60 mV
holding potential. The open probability (Po) and the conductance
of WT-CFTR were increased from ∼0.3 to ∼0.45 and 9.6± 0.3 pS
to 12.3± 0.4 pS, respectively (Fig. 3a, f, Supplementary Fig. 3c, d),
as a signature of the WT thermal activation, as reported16, 36. In
contrast, the initial activity of rescued ΔF508-CFTR (Po∼0.1) and
ΔF508-CFTR-2RK variant (Po∼0.2), containing the R29K and
R555K second site mutations, was reduced by ∼50% at 36 °C with
an inactivation half-life (t1/2) of ∼4 and ∼8 min, respectively
(Fig. 3b, c, f, Supplementary Fig. 3e, and Supplementary Table 1).
The 2RK mutation enhanced the recording success of the ΔF508-
CFTR without masking its processing defect and thermal
instability16, 27 and was preferentially used in subsequent studies.
Remarkably, the inactivation half-life (t1/2) of rescued ΔF508-
CFTR and ΔF508-CFTR-2RK, measured by the Po decay kinetics,
was ~15-fold faster in the BLM at 32–36 °C than at the PM
(t1/2∼120 min, 37 °C) of CFBE or HeLa cells, but was comparable
to that in excised patches16, 34, 37–39 at 37 °C (t1/2∼3–8 min)
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Fig. 2 Molecular chaperone activity maintains the limited transport competence of ΔF508- and P67L-CFTR. a FPMA of WT and ΔF508-CFTR calculated
from PM density and short-circuit current (Isc) with and without 24 h 3 μM VX-809 rescue, expressed as percentage of WT-CFTR expressing CFBE
(left panel). Isc was measured after sequential addition of 20 μM forskolin (fsk) and 100 μM genistein (gen), followed by CFTR inhibition with Inh172
(172, 20 μM). The FPMA (right panel) was calculated as the ratio of PM density and Isc, and normalized to WT. Means± SEM, n= 3; error bars in the right
panel are error propagation. b The effect of chaperone or co-chaperone knockdown on PM density, function and FPMA of the ΔF508-3HA in CFBE. The
rescued ΔF508-CFTR (30 °C, 48 h) was unfolded for 2 h at 37 °C. Hsp90α (90α), Hsp90β (90β), DNAJA1 (JA1), DNAJA2 (JA2), Aha1, Hsp70, and Hsc70
were silenced with 50 nM siRNA. Non-targeted siRNA served as controls. Function was determined by YFP quenching assay. c The effect of Hsc70 and
Hsp90 inhibition on the PM density and function of the ΔF508- and WT-CFTR-3HA in CFBE. The rescued ΔF508-CFTR (30 °C, 48 h) was unfolded (2 h at
37 °C) in the presence of 5 μM Pif and/or 5 μg ml−1 GA. Isc was measured as in a. Representative measurements are in the top panels. d The effect of Hsc70
and Hsp90 activity on the FPMA of the ΔF508- and P67L-CFTR in CFBE cells. Experiments were performed as in c. e Isc and PM density of P67L-CFTR in
CFBE as described in c. f The effect of Hsc70 and Hsp90 activity on ΔF508-CFTR FPMA in CFBE cells. CFBE cells, expressing ΔF508-CFTR with second
site mutations or rescued ΔF508-CFTR (30 °C, 48 h), were treated for 2 h at 37 °C with 5 μM Pif and 5 μg ml−1 GA. Experiments were performed as in c.
g Conformational rescue of the ΔF508-CFTR by low temperature plus VX-809 (3 μM, 24 h) prevents the loss of ΔF508-CFTR FPMA by Pif + GA in CFBE
cells. Experiments were performed as in c. Data are means± SEM, n= 3–4. *P< 0.05, **P< 0.01 and ***P< 0.001
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(Fig. 3g, Supplementary Fig. 3f). Since inactivation of PKA can be
ruled out based on the increasing Po of WT-CFTR during
temperature ramps (Supplementary Fig. 3a)35, the accelerated
inactivation may be attributed to the absence of molecular
chaperone profolding activity in the BLM, a presumption
tested next.
Chaperones favorably remodel ΔF508-CFTR gating energetics.
Recombinant Hsc70 with DNAJA240 that activates the Hsc70
ATPase, partially reversed the mutant thermal inactivation of
ΔF508-CFTR-2RK, as indicated by the increased Po at >30 °C. In
the presence of Hsc70/DNAJA2 the Po increased by ~2-fold at
36 °C (Fig. 3d, f, i). Similarly, Hsp90 in combination with Aha1
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that activates the chaperone ATPase2, conferred partial thermal-
resistance to ΔF508-CFTR-2RK activity and increased the Po by
∼1.5–2.1-fold at 30–36 °C (Fig. 3e, h, i).
The following observations indicate that speciﬁc
chaperone–cochaperone interactions and the ATPase cycle
activation are required for reverting the mutant gating defect41.
In the absence of the co-chaperones DNAJA2 and Aha1, the
conformational stabilization of the mutant by Hsc70 and Hsp90,
respectively, was reduced (Fig. 3f, h, i and Supplementary
Fig. 4a–f). Likewise, the ΔF508-CFTR-2RK thermal inactivation
was not attenuated by the ATPase deﬁcient Hsc70-K71M
variant40, replacing DNAJA2 with DNAJA1 or by using DNAJA2
alone (Fig. 3i, Supplementary Fig. 4a–f). Notably, the gating of the
native WT-CFTR was insensitive to Hsc70/DNAJA2 activity
(Supplementary Fig. 3h).
To reinforce the role of ATPase activity of Hsc70 in stabilizing
the near-native mutant, we took the advantage of the extensively
characterized DnaK/DnaJ/GrpE prokaryotic chaperone system42,
which has a similar peptide client recognition proﬁle to Hsc7043
and its refolding activity is stimulated by the nucleotide exchange
factor GrpE (Supplementary Fig. 4h)44. DnaK/DnaJ/GroE jointly
elicited comparable thermal stabilization of ΔF508-CFTR open
state as Hsc70/DNAJA2 (Fig. 4a, Supplementary Fig. 4i, j).
However, the stabilizing effect was abolished in the absence of
GrpE + DnaJ or GrpE, indicating that accelerated nucleotide
exchange is indispensable for the mutant refolding (Fig. 4a).
The Gibbs free energy difference between the open (O) and
closed (C) state of the channel (designated as ΔGO–C) was
calculated45, assuming a simpliﬁed, two-state gating model at
near equilibrium during the slow temperature ramp45, 46. The
WT O state thermodynamic stability relative to the C state
was considerably higher (ΔGO–C∼0.8± 0.4 kJ mol−1) than for
the mutants (ΔF508-CFTR-2RK: ΔGO–C∼5.8± 0.6 kJ mol−1
and ΔF508-CFTR: ΔGO–C∼8.3± 0.6 kJ mol−1), impeding ΔF508
open state prevalence at 36 °C (Supplementary Fig. 4g, right
panel). Both Hsc70/DNAJA2 and Hsp90/Aha1 reduced the
ΔGO–C of ΔF508-CFTR-2RK by ∼50% at 36 °C (Fig. 4b, c).
Comparable stabilization was achieved by DnaK/DnaJ/GroE
chaperones (Fig. 4a, c). Combination of Hsc70/Hsp90
chaperone systems further improved the open state stability
(ΔGO–C= 2.5± 0.5 kJ mol−1) (Fig. 4c, d).
Hsc70 improves ΔF508 gating kinetics and thermodynamics.
CFTR gating kinetics is deﬁned by the opening (ΔG‡C–O) and
closing (ΔG‡O–C) activation energies and calculated from dwell
time histograms of single channel O and C states. The WT mean
closed time (τC) decreased from ∼173 to ~114 ms, while the
mutant τC increased from ∼134 to ∼700 ms between 30 and 36 °C
(Fig. 5a, Supplementary Fig. 5a). The WT openings had a single O
state with a mean open time (τO) of ∼93–160 ms. The ΔF508
displayed a bimodal τO distribution, with a short (τO1 ∼10–30 ms,
O1) and a long (τO2 ∼352–570ms, O2) O states between 24 and
36 °C (Fig. 5b, left and middle panels), consistent with a three-
state gating model (Supplementary Fig. 5c). The contribution of
the short O1 state to the mutant activity was increased, while the
longer O2 state was decreased at 32–36 °C (Fig. 5b, Supplemen-
tary Table 2). The mean τO2 was also reduced by ∼30%, further
a
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decreasing the Po of ΔF508 at 36 °C (Fig. 5b, Supplementary
Fig. 5b and Supplementary Table 2).
Remarkably, Hsc70/DNAJA2 activity decreased the ΔF508
mean τC by ~4-fold (from ∼700 to ∼180 ms) and retained the
channel in the longer O2 state at 32–36 °C (Fig. 5b, Supplemen-
tary Fig. 5b and Supplementary Table 2). Since transitions
between the O1 and O2 states were extremely rare (Supplemen-
tary Table 3), the energetic calculation was based on the
O1(T)–C(T)–O2(T) gating model, where the C state likely includes
more than one conformation and all states are susceptible
to unfolding and conformational remodeling by chaperones at
>31 °C. By calculating the ΔGO–C from the opening and closing
activation energies (ΔG‡C–O and ΔG‡O–C), we conclude that
Hsc70/DNAJA2 decreased both the kinetic and thermodynamic
barrier of the mutant opening at 36 °C (Fig. 6a, b). The active
state stabilization could be attributed to decreased entropic
energy requirement that was partially off-set by increased
enthalpy of the open states by chaperone (Supplementary
Fig. 5e). The O136 °C and O236 °C were stabilized by ΔΔGO–C
∼4.8 and ∼3.2 kJ mol−1, respectively, by Hsc70 (Fig. 6a, b,
Supplementary Table 4). Only a modest effect was observed on
the mutant at 24 °C and on the WT (24–36 °C), consistent
with their near-native and native conformation, respectively
(Supplementary Table 4, Supplementary Fig. 5f). Thus, molecular
chaperones can partially buffer the severity of mutant conforma-
tional and functional defect at 36 °C by shifting the gating energy
landscape towards the WT (Fig. 6b).
Molecular chaperones target domain–domain assembly defects.
If chaperones recognize the non-native cytosolic domains
of ΔF508-CFTR, conformational stabilization of the NBD1
and NBD1–MSD1/2 interface by second site suppressor
mutations18, 47, 48 should render the mutant less susceptible to
chaperone activity in the BLM, as we observed in CFBE (Fig. 2f).
Accordingly, correction of the NBD1–MSD1/2 interface and
NBD1 folding defects by the R1070W and 3S suppressor muta-
tions or R1070W18 and low temperature rescue20, respectively,
were sufﬁcient to restore the Po and the ΔGO–C of ΔF508-CFTR
close to that of WT at 36 °C (Fig. 7a, b). The open state of
ΔF508-CFTR-R1070W became insensitive for stabilization
by Hsc70/DNAJA2 similar to that of the WT (Fig. 7a, b,
Supplementary Fig. 7a–d).
Stabilizing the ΔF508-NBD1 by the 3S mutation (Supplemen-
tary Fig. 3g) prevented the functional and gating energetic
correction by Hsc70/DNAJA2 (Fig. 7a, b, Supplementary Fig. 6e, f).
This suggests that stabilization of ΔF508-NBD1 folding defect
alone may reduce chaperone binding and/or uncouple the
channel cooperative domain assembly, which is completed post-
translationally with coupled domain folding and chaperone
assistance in vivo19, 20, 29, 49, 50. This inference is supported by
the observations that promoting CFTR coupled domain folding
by NBD1–NBD2 dimerization stabilized the ΔF508-CFTR
against thermal inactivation in the BLM. The NBDs dimerization
was facilitated by: (1) introduction the R1S revertant and
suppressor mutations51 (Supplementary Fig. 3g, Supplementary
Table 1), (2) inhibiting the ATPase activity of the composite site 2
of NBD dimer by the E1371S mutation52, or (3) using the
hydrolysable ATP analog, 2ʹdeoxy-ATP (dATP)53. The
NBD1–NBD2 dimer stabilization was reﬂected by the increased
Po and reduced ΔGO–C of the mutant at 36 °C (Fig. 7c, d). Jointly,
these results are consistent with the notion that the chaperone-
mediated conformational stabilization of ΔF508-CFTR can be
mimicked by enhanced NBD1–NBD2 heterodimerization.
Chaperones activation enhances ΔF508-CFTR PM function.
If the folding capacity of the proteostasis network is limited in
CF epithelia, increasing the chaperone activity may improve
ΔF508-CFTR function and stability at the PM. To test this
hypothesis, we ﬁrst augmented the stress-independent activation
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of the heat shock response by co-expressing the constitutively
active heat-shock factor-1 (cHSF1) fused to the destabilized
mutant FK506 binding protein 12 (FKBP-cHSF1)54 in ΔF508-
CFTR HeLa cells. Degradation of the FKBP-cHSF1 fusion was
prevented by the small molecule Shield-1, a stabilizer of FKBP
that causes transcriptional activation of the HSR with over-
expression of several cytosolic components of the ATP-dependent
chaperoning pathway (e.g., Hsp90, Hsp70s, and Aha1) and small
heat shock proteins as described54 (e.g., Fig. 8a, Supplementary
Fig. 8a). cHSF1 expression slowed down the ΔF508-CFTR
constitutive and GA-induced turnover at the PM (Fig. 8b).
Furthermore, cHSF1 augmented the FPMA of ΔF508-CFTR,
which could be attributed to improved channel function despite
reduced PM density of the mutant (Fig. 8c).
To assess the impact of the acutely increased Hsp90 activity on
ΔF508-CFTR functional and biochemical turnover at the PM,
we used the recently developed 2-phenyl benzofurane derivates
(CheCOSP-26, -27, -30 and -36), which were designed to
allosterically activate the Hsp90 ATPase cycle by binding to
the boundary between the middle and C-terminal domain of
Hsp9055, 56. These drugs acutely counteracted the GA-induced
ErbB2 destabilization at the PM (Supplementary Fig. 8b).
Exposing CFBE cells to CheCOSP-26, -27 or -30 for 2 h at
37 °C, augmented the ΔF508-CFTR PM function, measured by
the YFP assay, while modestly decreased its PM density. This
caused a ~1.6–2-fold increase in the FPMA, which was sensitive
to the CFTR blocker, Inh172 (Fig. 8d). The CheCOSP compounds
also delayed the mutant inactivation after 2 h at 37 °C,
as indicated by the 3-fold increased FPMA, compared to
non-treated cells, a phenomenon that prevailed in the presence
of VX-809 (Fig. 8e). These are consistent with the notion that
stimulation of Hsp90 cytosolic profolding activity can favorably
change the function and stability of ΔF508-CFTR at the PM.
Discussion
Although Anﬁnsen’s dogma postulates that the native state is
determined by the protein’s amino acid sequence, accumulating
evidences suggest that the polypeptide folding and its ﬁnal out-
come may be inﬂuenced by the nascent chain elongation rate,
interaction with the ribosome, posttranslational modiﬁcations,
chaperone activity as well as cytosolic crowding and composi-
tion2, 9, 57–59. Jointly, these were referred to as the physiologic
state by Anﬁnsen60. While chaperone-induced suppression of
misfolding and aggregation to increase the folding yield of soluble
proteins have been established, the malleability of the ﬁnal
fold and folding pathway by chaperones is not fully understood.
One of our most important ﬁndings is that the activity of
Hsc70/DNAJA2, Hsp90/Aha1 or DnaK/DnaJ/GrpE chaperone
systems can shift a mutant PM channel conformation towards
the native fold by reshaping the kinetic and thermodynamic
determinants of the gating energetics at the single-molecule level.
Furthermore, we show that the molecular chaperones, key players
of the cellular proteostasis network, are not only involved in the
degradation13 but can also suppress the functional folding defects
of mutant PM proteins by inﬂuencing the “ﬁnal” fold of
polypeptides.
The intracellular environment can cause structural changes to
intrinsically unstructured regions of the yeast prion protein
Sup35, as compared to its isolated native form, measured by
sensitivity-enhanced NMR9. The cytosol can also inﬂuence the
rate of folding and the thermodynamic stability of phosphogly-
cerate kinase (PGK), detected by Forster resonance energy
transfer61. These experiments did not identify constituents of the
cytosolic proteostasis network that are responsible for structural
changes of Sup35 and PGK. More recent results at single-
molecule level, however, suggested that both holdase (Skp)
and foldase (DnaK/DnaJ) chaperones can reduce the activation
energy of a membrane and a soluble protein (re)folding,
respectively11, 12. Similar conclusions were reached by examining
the effect of the trigger factor and GroEL/GroES on the (re)
folding kinetics of soluble client proteins at single molecule and
ensemble level, respectively7, 8, without assessing the ﬁnal fold
energetics. Our results provide evidence for both thermodynamic
and kinetic stabilization of a mutant integral PM protein
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(ΔF508-CFTR) by molecular chaperones. This mechanism may
modulate the phenotypic manifestation of conformational dis-
eases, caused by mutations in the ABC transporter superfamily62.
The recruitment of the Hsc70 and Hsp90
chaperon–cochaperone systems to the complex-glycosylated
ΔF508-CFTR during thermal unfolding (Fig. 1a–c) forms the
biochemical basis for reshaping the mutant unfolding trajectory
both at the PM and in BLM. This inference is supported by the
inverse correlation observed between the Hsc70/Hsp90 chaperone
activity and the severity of the mutant conformational and
functional defect. Attenuated or enhanced folding activity of
cytosolic chaperones led to decreased or increased function/sta-
bility of ΔF508-CFTR, respectively, at the PM. Both the ATPase
cycle of Hsc70 and the presence of DNAJA2, but not DNAJA1,
are required for the open state stabilization of the PM ΔF508-
CFTR at 36 °C. Likewise, activation of Hsp90 or DnaK/DnaJ
ATPase cycle by Aha1 or GrpE, respectively, was required to
increase the mutant open state stability, implying that beyond
binding, the chaperone ATPase cycle is indispensable for the
mutant conformational rearrangement. Considering that ΔF508-
CFTR largely resides in closed state during the manipulation of
molecular chaperone activity in the absence of exogenous PKA
activator, we suggest that both open and closed states are sus-
ceptible to conformational stabilization by chaperones.
While we still lack detailed molecular understanding of cha-
perones profolding activity, it is conceivable that they protect
unfolding intermediates from further intramolecular misfolding
and thereby prevent coupled domain disassembly of CFTR50. In
addition, entropic destabilization and stabilization of the mutant
during association–dissociation cycle of chaperones may permit
to relaunch the conformational search of unfolded cytosolic
domains for WT-like folding pathway(s). Molecular chaperones
may exert similar inﬂuence on the co- and post-translational
folding energy landscape of WT CFTR, considering that
the conformation of early folding intermediates of WT- and
ΔF508-CFTR partially overlap49, 63. In support, the limited
folding efﬁciency of WT-CFTR is enhanced by the NBD1 and the
NBD1–MSD interface stabilization20 and severely reduced by
inhibiting Hsp90 activity64.
The preferential requirement of DNAJA2 for folding over
DNAJA1, which contributes to CHIP- and ubiquitin-dependent
degradation of unfolded complex-glycosylated ΔF508-CFTR
from the PM, provides additional support for the specialized role
of distinct chaperone–co-chaperone complexes in a variety of
cellular processes, involving conformationally perturbed client
proteins65, 66. Importantly, the gating thermodynamics of the
ΔF508-CFTR during thermal unfolding was similarly altered by
the activity of Hsp90/Aha1 and DnaK/DnaJ/GrpE chaperone
system in the BLM. These observations, jointly, demonstrate that
the proteostasis system can favorably inﬂuence both the kinetic
barrier to refolding, and the relative thermodynamics of the ﬁnal
state, and suggest that the ﬁnal conformation(s) of the mutant is
inﬂuenced by molecular chaperones.
The more pronounced stabilization of the mutant CFTR
observed in vivo as compared to in vitro (Supplementary Fig. 3f)
may be attributed to the joint effect of entropic stabilization by
the crowded cytosolic environment and the coordinated foldase
activity of multiple cytosolic chaperone systems67, 68 including
numerous co-chaperones and adapter molecules, providing
broader substrate speciﬁcity and increased folding capacity than
accomplished in the BLM. Comparison of the chaperone-induced
functional stabilization of the glucocorticoid receptor (GR)69 and
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temperature rescued ΔF508-CFTR suggests that the Hsc70 cha-
perone system in addition to its unfoldase activity70 has substrate
speciﬁc foldase activity. While the Hsp70/Hdj1 system mediates
ligand dissociation and inactivation of the GR via localized
unfolding69, the Hsc70/DNAJ2, similarly to Hsp90/Aha1, was
sufﬁcient to partially protect against thermal destabilization of the
mutant in the BLM. In line, inactivation of both Hsc70 and
Hsp90 systems was required to unmask the profolding activity
of these chaperones on ΔF508-CFTR function and proteases
susceptibility in post-Golgi compartments. Furthermore, the
tendency to improve the function of thermally unfolded ΔF508-
CFTR was improved by the combination of Hsc70/DNAJ2 with
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Hsp90/Aha1 as compared to the effect of individual chaperones
(Fig. 4d). Additional experimentation is required to assess
whether functional coupling of the Hsc70 and Hsp90 folding
cycle by HOP and p23 co-chaperones could further enhance the
ΔF508-CFTR conformational rescue in the BLM.
Our results expand the previously assigned role of the
Hsc70/Hsp90 chaperone systems in the ubiquitin-dependent
degradation13 to the conformational maintenance of non-native
PM proteins. At the cellular level the mutant CFTR channel
resistance to thermal unfolding, measured by the FPMA, limited
proteolysis and PM stability, could be correlated with the folding
capacity of the Hsc70/Hsp90, as determined by manipulating the
chaperone activity using pharmacological or genetic means. In
support, the mutant susceptibility to chaperone-mediated
refolding was inﬂuenced by the severity of the ΔF508-CFTR
conformational defect. Second site suppressor mutations reduced,
while destabilization with VX-770 augmented the chaperone
susceptibility of ΔF508-CFTR at the PM. The former phenom-
enon was also reproduced in the BLM. At the single molecule
level we provided evidence that molecular chaperones partially
buffer the destabilizing consequence of genetic perturbations by
remodeling the gating energetics of ΔF508-CFTR, and by extra-
polation, of other marginally stable polypeptides (e.g., P67L-
CFTR) at the PM29. These results, jointly, demonstrate the
mutant channel conformational susceptibility to molecular cha-
perones as an unrecognized determinant of its ion transport
activity at the PM.
Based on these results and published data, we postulate that the
ultimate fate of marginally stable PM proteins is, at least in part,
deﬁned by the joint (re)folding and degradative activity of
molecular chaperone networks at the cell surface (Supplementary
Fig. 6). Chaperones in coordination with co-chaperones,
exchange factors and other conformational sensors can dis-
criminate between the irreversibly and transiently unfolded client
protein, a mechanism which complements an array of protein QC
steps that evolved for various subcellular compartments1, 2, 14.
Therefore, the loss-of-function phenotype and disease progres-
sion of conformational diseases afﬂicting PM proteins may be
inﬂuenced by organ and cell type speciﬁc, as well as person-to-
person variations in the proteostasis network activity (Supple-
mentary Fig. 6)1, 2, 71. Thus, the proteostasis activity is able to
tune the phenotypic presentation of conformational diseases by
inﬂuencing the folding energetic landscape in the context of cell
and host physiology, impacting survival and evolvability1, 2. These
considerations are anticipated to have a potential impact on the
utility of proteostasis modulators as therapeutics for human
disease.
Methods
CFTR expression constructs. CFTR variants were tagged either with three tandem
hemagglutinin epitopes (3HA) in the fourth extracellular loop or a single HA
epitope at the C-terminal tail25, 49. Nucleotide substitutions to generate CFTR
variants (e.g., P67L33) and second site mutations were introduced by overlapping
PCR mutagenesis as before and primers are listed in Supplementary Table 149.
DNAJA1, DNAJA2, Hsc70, and the ATPase deﬁcient Hsc70-K71M variants were
expressed by using pProEX-Hta (Clontech) expression vector. The cDNA of FKBP
fusion to the constitutively active heat shock factor 1 (FKBP-cHSF1) was a gift of R.
L. Wiseman54.
Cell lines. BHK-21 cell (ATTC CCL-10) lines, stably expressing the WT or mutant
CFTR variants, were selected in the presence of 500 μM methotrexate49. HeLa cells
(ATTC CCL2), expressing CFTR-3HA were stably transfected and selected in the
presence of 1–5 μg ml−1 puromycin as described34 and transduced with the FKBP-
cHSF1 encoding Lenti-X particles to generate double transfected cells. BHK-21 and
HeLa cells were grown in DMEM/F-12 (5% fetal bovine serum (FBS, Invitrogen))
and in DMEM (10% of FBS), respectively, at 37 °C in 5% CO2.
The generation of CFBE cell lines expressing inducible CFTR variants has been
described previously34. Brieﬂy, CFBE41o- (CFBE) is a human CF bronchial
epithelial cell line that has a CFTRΔF508/ΔF508 genotype72. These cells were grown
MEM (Invitrogen) containing 10% FBS (Invitrogen), 2 mM L-glutamine and 10
mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES). Plastic ﬂasks
for culturing these cells were coated with 10 μg ml−1 human ﬁbronectin (EMD), 30
μg ml−1 PureCol collagen preparation (Advanced BioMatrix), and 100 μg ml−1
bovine serum albumin (Sigma-Aldrich) in LHC basal medium (Invitrogen) (ECM-
mix). To generate the inducible expression of CFTR variants, CFBE cells were
consecutively transduced with lentiviral particles containing the cDNA for the
tetracycline-controlled transactivator and inducible CFTR using the Lenti-X
TetON Advanced Inducible Expression System (Clontech). For stable expression
the cells were selected with G418 (200 μg ml−1; InvivoGen) and puromycin (3 μg
ml−1, InvivoGen). The Lenti-X Packaging System (Clontech) was used to produce
lentiviral particles in HEK293 cells.
Hsp90 allosteric activators. The CheCOSP-26 and CheCOSP-27 allosteric Hsp90
ATPase activator synthesis and biological activity on Hsp90 have been previously
reported as one of the best Hsp90 ATPase activator, and were designated as
compound 18 and 19, respectively in Sattin et al.55. CheCOSP-30 and CheCOSP-36
were designed as modiﬁcations of CheCOSP27. The chemical synthesis of
CheCOSP-30 and CheCOSP-36 has been described56. Ongoing experiments show
that CheCOSP-30 and CheCOSP-36 activate Hsp90 ATPase and accelerate Hsp90
dimer closure kinetics, as measured by FRET analysis similar to CheCOSP2755.
Short-circuit current measurement. Short-circuit current (Isc) measurement of
polarized CFBE has been described previsouly59. Brieﬂy, for Isc measurements
CFBE cells were grown on ECM-mix coated 12 mm Snapwell ﬁlters (Corning) and
the CFTR expression was induced for ≥4 days with 500 ng ml−1 doxycycline. The
Snapwell ﬁlters were mounted in Ussing chambers (Physiologic Instruments) in
Krebs-bicarbonate Ringer buffer (140 mM Na+, 120 mM Cl−, 5.2 mM K+, 25 mM
HCO3−, 2.4 mM HPO4, 0.4 mM H2PO4, 1.2 mM Ca2+, 1.2 mM Mg2+, 5 mM
glucose, pH 7.4) which was mixed by bubbling with 95% O2 and 5% CO2. Apical
NaCl was replaced with Na+ gluconate to generate a chloride gradient and the
basolateral membrane was permeabilized with 100 μM amphotericin B (Sigma-
Aldrich). After establishing Isc conditions, measurements were performed at 37 °C
in the presence of 100 μM amiloride and recorded with the Acquire and Analyze
package (Physiologic Instruments). The results are expressed as μA cm−2 current
density. Measurements were performed in the presence of 100 μM amiloride.
Reconstitution of CFTR in BLM. WT- or ΔF508-CFTR variants enriched micro-
somes were isolated from stably transfected BHK-21 cell lines as described20, 45.
Brieﬂy, to accumulate temperature-rescued ΔF508-CFTR variants at the PM,
transfected BHK-21 cells were cultured at 26 °C for 36 h. To eliminate the ER-
associated core-glycosylated channels, cells were exposed to CHX (150 μg ml−1) for
14 h at 26 °C before the isolation of microsomes. WT-CFTR expressing cells were
cultured at 37 °C and treated with 150 μg ml−1 CHX for 3 h at 37 °C. Prepho-
sphorylated CFTR containing microsomes (20–60 μg total protein) were recon-
stituted from the cis-side of the BLM set-up, containing 0.8–1 ml buffer (300 mM
Tris-HCl, 10 mM HEPES (pH 7.2), 5 mM MgCl2, and 1 mM EGTA)20, 45. Final
ATP concentration in the cup was 2, or 0.5 mM when the effect of 2 mM
2´-deoxyadenosine 5´-triphosphate (dATP) was examined. All experiments were
performed in the presence of PKA catalytic subunit (100 Uml−1). In the BLM
studies, if it is not mentioned otherwise, we used the ΔF508-CFTR-2RK variant.
Current measurements were recorded with a BC-535 ampliﬁer (Warner
Instrument, Hamden, CT, USA) and the pClamp 8.1, 9, and 10.3 data acquisition
systems (Axon Instruments) at −60 mV holding potential, low pass ﬁltered at 200
Hz by an 8-pole Bessel ﬁlter, and digitized at 10 kHz by Digidata 1320 (Axon
Instruments). The BLM chamber temperature was raised from 23 to 37 °C at
∼1.4 °C min−1 rate using the CL-100 temperature controller (Warner Instrument).
The success rate of multiple or single ΔF508-CFTR-2RK channel functional
reconstitution with complete temperature ramp protocol was ~2 or ~0.7%,
respectively, in the BLM. The functional incorporation success of ΔF508-CFTR
and ΔF508-CFTR-2RK into the BLM was ~1 and ~2 %, respectively, based on a
~300 ΔF508-CFTR and ~1800 ΔF508-CFTR-2RK incorporation attempts.
Energetic analysis of the CFTR gating cycle. Records were digitally ﬁltered at
50 Hz by using Clampﬁt 10.3 (Axon Instruments) and events were idealized using a
half amplitude-threshold. Events shorter than 10 ms were rejected from further
analysis. The single channel open probability (PO) was determined using the event
detection features of the Clampﬁt 10.3 software, as NPO divided by the number of
channels (N).
Single channel dwell times were determined from histograms. We used
Gaussian distribution with nonlinear least-squares Levenberg–Marquardt
algorithm for dwell time histogram ﬁtting. Histograms were created from open and
closed dwell times using logarithmic x-axes with 10 bins per decade, using the
Clampﬁt10.3 software. Analysis of the gating kinetics and thermodynamics was
performed from single channel current records. Activation enthalpy and entropy of
single channel gating transitions were calculated from opening and closing rate
constants [kO=(τC−1) and kC=(τO−1), respectively] according to the equation73
ln kð Þ ¼ ΔHzR1T1þΔSzR1þln νz;
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where R is the gas constant (8.31451 J mol−1 K−1), ΔH‡ is the activation enthalpy,
and ΔS‡ is the activation entropy for either channel opening or closing. We used
ν‡~106 s−1 as described for protein folding73. One or two component ﬁts were
calculated by linear regression analysis for ln(kO) and ln(kC) plotted against T−1.
ΔH‡, ΔS‡, and ΔG‡ were calculated from the Arrhenius equation
(ΔG‡C–O=ΔH‡C–O−TΔS‡C–O and ΔG‡O–C=ΔH‡O–C−TΔS‡O–C, see Fig. 6b and
Supplementary Table 4). The Gibbs free energy of single channel open states
was calculated from the activation energies of opening and closing according to
ΔGO–C=ΔG‡O–C−ΔG‡C–O.
To estimate steady-state gating energetics using both single and multichannel
recordings, the ln Ke values (where Ke is the equilibrium gating constant and
Ke= Po (1−Po)−1) were plotted as a function of 1000T−1 (K−1). The ΔHO–C and
ΔSO–C were calculated from Van’t Hoff plots;
lnKe ¼ ΔHOCR1T1þΔSOCR1
The Gibbs free energy of the open state relative to the closed state was derived
from the equations of ΔGO–C= −RT ln(Ke), where R is the universal gas constant
and T is the absolute temperature, and ΔGO–C=ΔHO–C−TΔSO–C.
CFTR limited proteolysis. Limited proteolysis was performed published
previously50. Brieﬂy, WT or ΔF508 CFTR containing microsomes were digested
with protease in PBS for 15 min at 4 °C. To terminate the proteolysis, 1 mM
phenylmethysulfonylﬂuoride (PMSF) and 5 mM EDTA was added followed by
denaturation with 2× Laemmli sample buffer at 37 °C for 10 min.
Immunoblotting and immunoprecipitation. Immunoblotting of cell lysates and
immunoprecipitates (IP) were performed as previously described24. Anti-ErbB-2
(9G6, #16899) was purchased from Abcam (Cambridge, MA). Co-IP of chaperons
with WT-, ΔF508-, and rescued ΔF508-CFTR-HA (24 h at 26 °C and 5% glycerol)
was performed after solubilization of BHK-21 cells in 150 mM NaCl, 20 mM
Tris 0.1% NP-40, pH7.4 and protease inhibitors 5 μg ml−1 leupeptin, 5 μg ml−1
pepstatin, 1 mM PMSF and 10 mM iodoacetamide. A total of ~5 mg BHK-21 lysate
was used for each Co-IP. The lysate was incubated with anti-HA antibody for 1
h and then CFTR-antibody complexes were adsorbed on 80 μl of 50% protein
G-beads (GE Healthcare, Uppsala, Sweden) for 1 h at 4 °C. The beads were washed
three times and proteins were eluted in 2× Laemmli sample buffer (20 min, 37 °C).
Co-IP of co-chaperones with CFTR was performed after cross-linking with 0.1 mM
dithiobis[succinimidyl propionate] (DSP), of cells exposed to CHX chase at 26 or
37 °C to eliminate the core-glycosylated forms as described for Fig. 1a. Prior to
SDS-PAGE, DSP was reduced with 100 mM DTT. The antibodies were used: HA
(HA.11, clone 16B12, Cederlane), Hsc70 (SPA-815, Stressgen), Hsp40 (SPA-400,
Stressgen), and Hsp90 (CA1016, Calbiochem) (Supplementary Table 5).
CFTR PM density measurement. CFBE cells were seeded on extracellular matrix-
mix coated 12mm Snapwell ﬁlters (Corning) at a density of 1 × 105 cells cm−2.
CFTR expression was induced with 250–500 ngml−1 doxycycline (dox) for
4–5 days. The PM density and stability of CFTR-3HA in BHK-21 and CFBE cells
was measured by cell surface ELISA24, using anti-HA antibody (MMS101R,
Covance) and secondary HRP-conjugated goat anti-mouse IgG antibody
(GE Healthcare) in PBSCM (phosphate buffered saline with 0.1mM CaCl2 and 1
mM MgCl2 at pH 7.4) supplemented with 0.5% bovine serum albumin on ice as
described24. Excess antibody was removed by extensive washing and speciﬁc binding
was determined with the Amplex-Red (Invitrogen) as HRP substrate. The ﬂuores-
cence intensity was measured at 544 nm excitation and 590 nm emission wave-
lengths with a POLARstar OPTIMA (BMG Labtech) ﬂuorescence plate reader24.
Iodide efﬂux assay. CFTR mediated iodide efﬂux was determined in transfected
HeLa cells74. Brieﬂy, CFTR was activated by PKA agonist-cocktail containing
20 μM forskolin, 0.25 mM 8-(4-chlorophenylthio)-adenosine 3´,5´-cyclic mono-
phosphate (cpt-cAMP), 0.5 mM 3-isobutyl-1-methylxanthine (IBMX) and 50 μM
genistein. The iodide efﬂux into the extracellular compartment was monitored with
an iodide-selective electrode. CFTR-mediated iodide transport was calculated from
peak value of iodide release after normalizing for protein content. The efﬂux rate of
NT siRNA transfected cells was used as negative control24.
Halide-sensitive yellow ﬂuorescent protein assay. CFTR function measurement
by the halide-sensitive yellow ﬂuorescent protein assay has been described pre-
viously59. Brieﬂy, CFBE cells harboring the inducible expression of ΔF508-CFTR
were generated to co-express the halide sensor YFP-F46L/H148Q/I152L by lenti-
viral transduction. Double-expressing cells were enriched by ﬂuorescence-activated
cell sorting. YFP-expressing cells, seeded onto 96-well microplates at a density
of 2 × 104 cells per well, were induced for ΔF508-CFTR expression for 2–4 days at
37 °C, in some cases followed by low temperature—rescued for an additional 48 h
at 26 °C. During the assay the CFBE cells were incubated in 50 µl per well
phosphate-buffered saline (PBS)–chloride (140 mM NaCl, 2.7 mM KCl, 8.1 mM
Na2HPO4, 1.5 mM KH2PO4, 1.1 mM MgCl2, 0.7 mM CaCl2, and 5 mM glucose, pH
7.4). CFTR was activated by 50 µl well-wise injection of activator solution (20 mM
forskolin, 0.5 mM IBMX, 0.5 mM cpt-cAMP, 100 µM genistein). Then the
quenching reaction was started by the injection of 100 µl of PBS-iodide, in which
NaCl was replaced with NaI, while the YFP-ﬂuorescence was recorded at 485-nm
excitation and 520-nm emission for 36 s at a 5-Hz acquisition rate in a POLARstar
OPTIMA (BMG Labtech) ﬂuorescence plate reader. Background values were
subtracted and the YFP signal was normalized the ﬂuorescence before NaI injec-
tion. The iodide inﬂux rate was calculated by linear ﬁtting to the initial slope.
Conformational stability measurements. Differential scanning ﬂuorimetry of
isolated NBD1 variants (7–12 mM) was performed in 150 mM NaCl, 20 mM
MgCl2, 10 mM HEPES, and 2.5 mM ATP at pH 7.5 in the presence of 4× Sypro
Orange, essentially as described20, 75, 76. Unfolding was monitored between 25 and
70 °C with the Stratagene Mx3005p (Agilent Technologies, La Jolla, CA, USA) and
analyzed by using XLFit (IDBS, London, UK). Alternatively, melting curves were
recorded between 10 and 70 °C with the QuantStudio7 Flex qPCR machine (Life
Technologies, Carlsbad, CA, USA) and analyzed using the Protein Thermal Shift
Software v1.0 (Applied Biosystems, NY, USA). In both cases the temperature ramp
rate was 0.017 °C s−1 and data were ﬁtted with a Boltzmann sigmoidal function.
Following chaperone inhibition, the conformational stability of ΔF508-CFTR in
its native environment was probed by limited tryspinolysis and immunoblotting50,
using the 660 NBD1 speciﬁc monoclonal antibody, kindly provided by
Dr. J. Riordan and the CFFT20. Microsomes were isolated from stably transfected
BHK-21 cells after low temperature rescue (26 °C, 48 h) and unfolding (37 °C,
1.5 h) in the presence of DMSO or piﬁthrin-μ (Pif, 5 μM) and GA (5 μg ml−1)50.
To eliminate endogenous core-glycosylated CFTR, BHK-21 cells were treated with
CHX (150 μg ml−1) during the 37 °C incubation. Limited proteolysis was
performed at the indicated trypsin concentrations (Worthington Biochemical,
Lakewood, NJ, USA) for 15 min on ice. Trypsinolysis was terminated by
10 mgml−1 soybean trypsin inhibitor (Sigma-Aldrich), 10 mM PMSF and 2×
Laemmli sample buffer. The remaining amount of the trypsin-resistant complex-
glycosylated ΔF508-CFTR was quantiﬁed by densitometric analysis of anti-HA
immunoblots with multiple exposures using a DuoScan transparency scanner and
the NIH ImageJ v1.6 software (NIH, http://rsb.info.nih.gov/ij/) and expressed as
the percentage of the initial amount.
Luciferase refolding assay. DnaK, DnaJ, and GrpE were expressed and puriﬁed by
conventional techniques using expression plasmids (pDS56-dnaK-Chis6, pUHE21-
2fdD12-dnaJ, pZE2-Pzl-grpE) and strains (BB1553, W3110), kindly provided M
Mayer according to published protocols77–79. Recombinant Fireﬂy luciferase (Sigma-
Aldrich) refolding experiments were performed as described42. Brieﬂy, following the
denaturation of Fireﬂy luciferase (8 µM) in 6M Gu-HCl (5min, 26 °C), refolding
was initiated by 100-fold dilution into 40mM HEPES/KOH pH 7.5, 50mM K-
acetate, 2 mMMg-acetate, and 2mM ATP at 30 °C in the absence or presence of the
indicated chaperone and co-chaperone DnaK (800 nM), DnaJ (160 nM) and GroE
(400 nM). Luciferase activity was measured as a function of incubation time by
luminometry in the presence of 70 µM D-luciferin and 5mM ATP.
Vesicular pH measurements by FRIA. The postendocytic fate of low-temperature
rescued ΔF508-CFTR after internalization from the PM was monitored by ﬂuor-
escence ratio image analysis (FRIA) in CFBE cells80. The FRIA of endocytic vesicles
containing CFTR cells was preformed as before80. Brieﬂy, ﬁlter-grown CFBE was
allowed to polarize for 5 days and temperature rescued for 48 h at 30 °C. DMSO or
VX-809 was added for 24 h and kept during the experiment. GA (5 µM) and Pif
(5 μM) were added to the apical site of Transwell chamber during anti-HA
antibody incubations on ice, and kept at 37 °C during the chase. Then, cells
were labeled by FITC-conjugated goat anti-mouse secondary Fab (Jackson
ImmunoResearch) on ice. Internalization was allowed for 30 min at 37 °C. FRIA
was determined by an AxioObserver Z1 (Carl Zeiss MicroImaging) inverted
ﬂuorescence microscope equipped with an X-Cite 120Q ﬂuorescence illumination
system (Lumen Dynamics Group) and an Evolve 512 EMCCD (electron-multi-
plying charge-coupled device) camera (Photometrics Technology) at 495± 5 nm
and 440± 10 nm excitation and at 535± 25 nm emission wavelength. MetaFluor
(Molecular Devices) software was used for data acquisition and analysis.
siRNA transfection. Hsc70 was knocked down (KD) in HeLa cells, stably
expressing WT- or ΔF508-CFTR-3HA, by using 50 nM GENOME SMARTpool
siRNA (siHsc70) (Dharmacon-Thermo Fisher Scientiﬁc, Rockford, IL) and
Oligofectamine (Invitrogen) according to the manufacture’s instructions.
Non-targeting (NT) siRNA (D-001210-01, Dharmacon) was used as a negative
control. KD efﬁciency was veriﬁed by quantitative immunoblot analysis after 4 days
of siRNA transfection. Low temperature rescued ΔF508-CFTR (26 °C for 36 h) was
unfolded for 2.5 h at 37 °C in the absence or presence of chaperone inhibitors as
indicated.
siGENOME SMARTpool or single siRNA (Dharmacon-Thermo Fisher
Scientiﬁc, Rockford, IL) listed in Supplementary Table 5 were transiently
transfected into CFBE cells using RNAiMAX reagent (Thermo Fisher Scientiﬁc)
according to the manufacturer’s instructions. Cells were trypsinized and seeded
into 24 well plates 5 h before siRNA transfection. Knockdown efﬁciency of the
target proteins was veriﬁed by quantitative immunoblot analysis. Experiments were
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performed 4 days after siRNA transfection. Detailed information on siRNAs and
antibodies are described in Supplementary Table 5. In most case, the KD efﬁciency
was > 60%.
Immunostaining. Immunostaining of CFTR and HSF-1 was performed in ΔF508-
CFTR-3HA and FKBP-cHSF1 expressing HeLa cells. HeLa cells were ﬁxed with 4%
paraformaldehyde and permeabilized with 0.2% Triton X-100, followed by
blocking with 0.5% BSA in PBS, supplemented with 0.1 mM CaCl2 and 1 mM
MgCl2, pH 7.4 (PBSCM). FKBP-cHSF1- and ΔF508-CFTR-3HA-expressing HeLa
cells were costained with anti-HA (dilution 1:1000) and anti-HSF1 (NB300-730,
NovusBio, dilution 1:1000) antibodies. We used Alexa Fluor-488 and Alexa
Fluor-555 conjugated secondary antibodies (Invitrogen). Images were obtained on
an LSM780 laser confocal ﬂuorescence microscope (Carl Zeiss, Jena, Germany).
Statistical analysis. Results are presented as means± SEM for the indicated
number of experiments as biological replicates. Statistical analysis was performed
by two-tailed, unpaired Student’s t-test with the means of at least three indepen-
dent experiments and ≥95% conﬁdence level was considered signiﬁcant. The
normal distribution was validated by calculating the skew factor and analyzing the
data on a normal probability plot. If this condition could not be conﬁrmed for
some of the BLM data, Mann–Whitney U test was used for calculating the P-values
(www.socscistatistics.com/tests/mannwhitney/Default2.aspx).
To ensure acceptable reproducibility, biological replicates were performed and
the number of independent experiments is indicated in each ﬁgure legend or in the
ﬁgure. Depending on the speciﬁc assay, the number of technical replicates in
individual experiments was as follows. Short circuit current measurement, two;
halide-sensitive YFP transport measurement, four; iodide-selective chloride
transport measurement, three; PM CFTR density determination by ELISA, two to
four; luciferase refolding, two or three, and melting assay, three. In each FRIA
studies several hundreds of vesicles were analyzed from several cells in the
indicated number of independent experiments. For limited proteolysis,
immunoblots/IP and bilayer measurements technical replicates for feasibility
reasons were not used and the number of biological replicates is indicated in the
ﬁgure legends.
Data availability. All data supporting the ﬁndings of this study are available from
the corresponding author upon reasonable request.
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